Pharmaceutical composition with efficacy of resisting gastrointestinal cancer

Abstract

The invention discloses a pharmaceutical composition with the efficacy of resisting gastrointestinal cancer. The pharmaceutical composition is prepared from the following components in parts by weight: 4 to 8 parts of hypha of hericium erinaceus, 4 to 8 parts of black nightshade herb, 4 to 8 parts of clerodendrum bungei, 1 to 3 parts of radix notoginseng, 1 to 3 parts of fructus ligustri lucidi and 1 to 3 parts of pericarpium citri reticulatae. According to the pharmaceutical composition disclosed by the invention, by matching the hypha of hericium erinaceus with the black nightshade herb and the clerodendrum bungei or matching the hypha of hericium erinaceus with the black nightshade herb, the clerodendrum bungei, the radix notoginseng, the fructus ligustri lucidi and the pericarpium citri reticulatae, unexpected technical effects are generated, and a remarkable effect of resisting the gastrointestinal cancer is realized. Compared with the separate hypha of hericium erinaceus, the pharmaceutical composition disclosed by the invention is higher in activity; no toxic or side effects are found from in vitro or in vivo antitumor tests. The pharmaceutical composition is safe in medication, and can be used for preparing a medicine for resisting the gastrointestinal cancer.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for resisting gastrointestinal cancer. Background technique [0002] Gastrointestinal cancer is one of the most common malignancies, accounting for approximately 25% of all cancers according to the American Cancer Society. Gastrointestinal cancer ranks fourth in the world in terms of incidence of cancer. China has a high incidence and mortality rate (50% of deaths occur in China). The treatment of gastrointestinal cancer includes surgery, chemotherapy, Radiation therapy and immunotherapy. Chemotherapy is the most commonly used method, but it cannot be cured completely, and the toxic and side effects are relatively large. In the past few decades, the development of molecular biology has made some progress in the treatment of gastrointestinal cancer, but drug resistance and toxicity still limit the progress of treatment methods. ...

AI Technical Summary

Problems solved by technology

However, there are only more than 20 species that are widely used in clinical practice, and the 2015 edition of the "Chinese Pharmacopoeia" clearly included 7 species, which shows that the research on biological medicinal bacteria is still far from perfect, and there is a lot of room for development.

Images